GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation
Rational design
SIRT2
DOI:
10.1042/bj20090110
Publication Date:
2009-03-17T15:32:00Z
AUTHORS (4)
ABSTRACT
O-GlcNAcylation is an essential, dynamic and inducible post-translational glycosylation of cytosolic proteins in metazoa can show interplay with protein phosphorylation. Inhibition OGA (O-GlcNAcase), the enzyme that removes O-GlcNAc from O-GlcNAcylated proteins, a useful strategy to probe role this modification range cellular processes. In present study, we report rational design evaluation GlcNAcstatins, family potent, competitive selective inhibitors human OGA. Kinetic experiments recombinant reveal GlcNAcstatins are most potent reported date, inhibiting sub-nanomolar nanomolar range. Modification GlcNAcstatin N-acetyl group leads up 160-fold selectivity against lysosomal hexosaminidases which employ similar substrate-assisted catalytic mechanism. Mutagenesis studies bacterial OGA, guided by structure complex, provides insight into conserved residues active site. cell-permeant and, at low concentrations, effectively modulate intracellular levels through inhibition cell lines. Thus these compounds tools study biology O-GlcNAc.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (47)
CITATIONS (75)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....